Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 34 studies | 32% ± 12% | |
endothelial cell of lymphatic vessel | 18 studies | 32% ± 12% | |
capillary endothelial cell | 13 studies | 27% ± 10% | |
vein endothelial cell | 12 studies | 31% ± 10% | |
endothelial cell of artery | 11 studies | 39% ± 16% | |
endothelial cell of vascular tree | 9 studies | 33% ± 10% | |
glomerular endothelial cell | 3 studies | 41% ± 2% | |
endothelial cell of sinusoid | 3 studies | 38% ± 21% | |
hematopoietic stem cell | 3 studies | 17% ± 3% |
Insufficient scRNA-seq data for expression of MYCT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2972.33 | 459 / 459 | 97% | 11.19 | 1086 / 1118 |
thymus | 100% | 1832.79 | 652 / 653 | 96% | 14.03 | 583 / 605 |
lung | 100% | 2205.24 | 578 / 578 | 92% | 7.00 | 1066 / 1155 |
prostate | 91% | 621.41 | 224 / 245 | 90% | 5.95 | 454 / 502 |
kidney | 97% | 688.51 | 86 / 89 | 77% | 22.43 | 691 / 901 |
bladder | 95% | 938.57 | 20 / 21 | 77% | 4.54 | 390 / 504 |
esophagus | 85% | 766.16 | 1232 / 1445 | 83% | 4.99 | 151 / 183 |
intestine | 90% | 782.83 | 868 / 966 | 75% | 4.28 | 396 / 527 |
stomach | 76% | 456.41 | 273 / 359 | 85% | 5.55 | 244 / 286 |
uterus | 99% | 1365.34 | 168 / 170 | 61% | 3.09 | 282 / 459 |
brain | 61% | 311.90 | 1611 / 2642 | 99% | 8.19 | 696 / 705 |
adrenal gland | 62% | 313.87 | 160 / 258 | 92% | 10.27 | 212 / 230 |
liver | 40% | 180.75 | 91 / 226 | 87% | 5.46 | 355 / 406 |
skin | 58% | 390.79 | 1053 / 1809 | 63% | 3.48 | 296 / 472 |
ovary | 63% | 418.09 | 114 / 180 | 56% | 1.98 | 240 / 430 |
pancreas | 13% | 50.62 | 42 / 328 | 96% | 9.33 | 171 / 178 |
adipose | 100% | 3624.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 3071.21 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 99% | 1069.72 | 856 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 581.34 | 748 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 80% | 774.25 | 1069 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 2.78 | 23 / 29 |
tonsil | 0% | 0 | 0 / 0 | 76% | 3.14 | 34 / 45 |
eye | 0% | 0 | 0 / 0 | 18% | 0.48 | 14 / 80 |
peripheral blood | 0% | 0.93 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0061484 | Biological process | hematopoietic stem cell homeostasis |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0016604 | Cellular component | nuclear body |
Gene name | MYCT1 |
Protein name | MYC target 1 Myc target protein 1 (Myc target in myeloid cells protein 1) Myc target 1 transcript variant 1 |
Synonyms | MTMC1 MTLC |
Description | FUNCTION: May regulate certain MYC target genes, MYC seems to be a direct upstream transcriptional activator. Does not seem to significantly affect growth cell capacity. Overexpression seems to mediate many of the known phenotypic features associated with MYC, including promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation (By similarity). . |
Accessions | E9PQ55 H0YDV5 D6Q1S4 ENST00000529453.1 Q8N699 ENST00000367245.6 ENST00000532295.1 |